Eiichiro Yumoto
Okayama University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eiichiro Yumoto.
Journal of Gastroenterology and Hepatology | 2002
Eiichiro Yumoto; Toshihiro Higashi; Kazuhiro Nouso; Harushige Nakatsukasa; Keishi Fujiwara; Tadashi Hanafusa; Yasuhiro Yumoto; Tadao Tanimoto; Masashi Kurimoto; Noriaki Tanaka; Takao Tsuji
Background and Aims: The aim was to determine the role of T‐helper (Th)1/Th2 cytokine responses in the clinical outcome of patients with acute liver injury.
British Journal of Surgery | 2010
Yasuhiro Yumoto; Tomohiko Yagi; Shuichiro Sato; Kazuhiro Nouso; Yoshiyuki Kobayashi; M. Ohmoto; Eiichiro Yumoto; I. Nagaya; Harushige Nakatsukasa
Assessment of hepatic functional reserve is important in hepatic resection. The aim of this study was to evaluate the role of hepatic asialoglycoprotein receptor (ASGP‐R) analysis in the preoperative estimation of remnant liver function in liver surgery.
Cancer Chemotherapy and Pharmacology | 1992
Yasuhiro Yumoto; Kenji Jinno; Shinichi Inatsuki; Shosuke Moriwaki; Tadashi Hanafusa; Eiichiro Yumoto; Tetsuya Slriota; Toshihiro Higashi; Norio Koide; Hajime Hada; Kenya Murase; Ken Hamamoto; Takao Tsuji
SummaryAfter 12 days of culture, VX2 carcinoma cells were inoculated into the liver of 16 rabbits; 14 days later,131I-labeled iodized oil ([131I]-Lp) suspended in lipiodol was injected into the hepatic artery. Selective accumulation of the contrast material in the tumor for an extended time was evident on X-rays and hepatic scintiphotographs. The antitumor effect was remarkable. [131I]-Lp agents warrant further examination for their clinical usefulness. Internal radiation therapy by transcatheter hepatic arterial injection of [131I]-Lp (group A) was evaluated in 9 patients with hepatocellular carcinoma (HCC, tumor stage III or IV) associated with liver cirrhosis (LC) and compared with combination therapy of Lp-TAE (group B) in 18 patients with HCC (tumor stage III or IV) associated with LC. In group A, serum AFP levels dropped rapidly in eight of the nine patients who had an elevated intial level of more than 500 ng/ml. The average reduction in tumor size was 50% in eight cases as determined by computed tomography. Histological examination of one resected liver specimen at 3 months after the third injection of [131I]-Lp revealed microscopic features highly suggestive of a radiation effect in the [131I]-Lp-containing area. The 1-year survival value for patients with HCC was estimated at 49.0% using the Kaplan-Meier method. The survival of patients treated with internal radiation therapy tended to be better than that of those treated with Lp-TAE (P=0.119).
Cancer Chemotherapy and Pharmacology | 1994
Yasuhiro Yumoto; Masakichi Umeda; Kanji Ohshima; Hiromichi Ogawa; Tatsuo Kurokawa; Motonao Kajitani; Eiichiro Yumoto; Tadashi Hanafusa; Hajime Tsuboi; Toshihiro Higashi; Tsuyoshi Mitani; Takao Tsuji
To improve the results of hepatectomy in cirrhotic patients, the likely reserve function of the liver was evaluated before surgery. Asialoglycoprotein receptor (ASGP-R) is a hepatic cell surface receptor specific for galactose-terminated glycoproteins. Technetium-99m-diethylene triamine pentaacetic acid-galactosyl human serum albumin (99mTc-GSA) is a newly developed analog ligand to ASPG-R. The probable functional reserve of the remnant liver after hepatectomy was estimated preoperatively as the hepatic binding protein (HBP) concentration specific for ASGP-R on the hepatocellular membrane of the remnant liver. This estimate was based on the effective liver volume rate, obtained by the uptake of99mTc-GSA. In all, 3 normal volunteers, 3 patients with chronic hepatitis (CH), 9 patients with liver cirrhosis (LC), 2 patients with hepatic cystadenoma, 3 patients with hepatocellular carcinoma (HCC) associated with CH, and 21 HCC patients with LC were studied. The mean value ±SD obtained for HBP in normal volunteers (three cases) and in patients with mild (four cases), moderate (two cases), and severe liver damage (five cases) were 0.74±0.03 μM, 0.43±0.042 μM, 0.31±0.05 μM, and 0.20±0.05 μM, respectively. Most of the cases in which the preoperative HBP of the remnant liver was above 0.22 μM had a good postoperative course irrespective of the type of hepatectomy. On the other hand, in subjects with a remnant liver HBP of between 0.22 and 0.11 μM, postoperative severe liver dysfunction occurred in about 50% of cases. In all cases with a remnant liver HBP below 0.1 μM, the prognosis was very poor, indicating that hepatectomy should be avoided. The HBP concentration detected by the99mTc-GSA study is a very sensitive indicator of changes in the hepatic functional reserve, and the HBP value for the functional reserve of the remnant liver is extremely useful for estimating the liver function before and after hepatectomy.
Journal of Gastroenterology and Hepatology | 2003
Toru Onishi; Kazuhiro Nouso; Toshihiro Higashi; Nobuyuki Toshikuni; Harushige Nakatsukasa; Yoshiyuki Kobayashi; Masayuki Uemura; Eiichiro Yumoto; Keishi Fujiwara; Shuichiro Sato; Shinichiro Nakamura; Junko Yokoyama; Tadashi Hanafusa; Yasushi Shiratori
Background and Aim: Telomerase is the enzyme that synthesizes telomeric DNA, and the activation of telomerase is closely related to cellular immortality. Telomerase activity has been reported in many human cancer tissues and is regulated by the expression of human telomerase reverse transcriptase (hTERT). The aim of the present study was to identify hTERT‐expressing cells in human liver tissues and evaluate the feasibility of the hTERT promoter for gene therapy of hepatocellular carcinoma (HCC).
Comparative Hepatology | 2004
Eiji Matsumoto; Harushige Nakatsukasa; Kazuhiro Nouso; Shinichiro Nakamura; Mayumi Suzuki; Yoshiyuki Kobayashi; Masayuki Uemura; Syuichiro Sato; Eiichiro Yumoto; Junko Yokoyama; Sou Tsuboi; Hironori Tanaka; Yoshiataka Takuma; Tatsuya Fujikawa; Yasushi Shiratori
Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies in Japan. Invasion and metastasis of HCC are frequently observed during the development of HCCs, and are regulated by matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs). We have previously reported the strong expression of TIMP-1 and TIMP-2, and cellular localization of the transcripts in HCCs [1]. But the mechanisms of invasion and metastasis of HCCs, and particularly the role of TIMPs are still unclear. The purpose of this study was to examine the tissue concentration of the TIMP-1 and to study the potential involvement of TIMP-1 in the development of HCCs.
Cancer Letters | 2002
Tadashi Hanafusa; Yasuhiro Yumoto; Kazuhiro Nouso; Harushige Nakatsukasa; Toru Onishi; Tatsuya Fujikawa; Mayumi Taniyama; Shinichiro Nakamura; Masayuki Uemura; Yoshitaka Takuma; Eiichiro Yumoto; Toshihiro Higashi; Takao Tsuji
World Journal of Gastroenterology | 2008
Seiyuu Suzuki; Shoji Hirasaki; Fusao Ikeda; Eiichiro Yumoto; Hiromichi Yamane; Minoru Matsubara
World Journal of Gastroenterology | 2007
Shoji Hirasaki; Hiromitsu Kanzaki; Minoru Matsubara; Kohei Fujita; Fusao Ikeda; Hideaki Taniguchi; Eiichiro Yumoto; Seiyuu Suzuki
International Journal of Oncology | 2005
Eiichiro Yumoto; Harushige Nakatsukasa; Tadashi Hanafusa; Yasuhiro Yumoto; Kazuhiro Nouso; Eiji Matsumoto; Toru Onishi; Yoshitaka Takuma; Hironori Tanaka; Tatsuya Fujikawa; Mayumi Suzuki; Masayuki Uemura; Yasushi Shiratori